Clinical Approach to Fever
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Fever
Fever is one of the most common presenting complaints in clinical practice, accounting for approximately 5% of all emergency department visits and up to 30% of outpatient primary care encounters. In adults, fever accompanies a wide spectrum of conditions ranging from self-limited viral infections to life-threatening sepsis. While most febrile episodes in immunocompetent adults are caused by benign, self-resolving infections, fever can also be the sole presenting sign of serious bacterial infection, malignancy, or inflammatory conditions. Understanding the systematic approach to fever is essential for every clinician.
Definition
Fever is defined as an elevation of body temperature above the normal daily variation, typically considered as a core body temperature of 38.0°C (100.4°F) or higher. Normal body temperature ranges from 36.1°C to 37.2°C (97°F to 99°F) and follows a circadian rhythm, with the lowest temperatures occurring in early morning and peak temperatures in late afternoon. Fever represents a regulated rise in the hypothalamic set point, distinguishing it from hyperthermia, where temperature rises uncontrollably above the set point.
Key Epidemiology
- Fever accounts for approximately 5-10% of all emergency department visits in adults
- Up to 30% of primary care visits involve fever as a presenting complaint
- Infections cause approximately 75-80% of acute febrile episodes
- Fever of unknown origin has an identifiable cause in approximately 90% of cases with thorough investigation
- Serious bacterial infection is present in approximately 10-15% of febrile adults presenting to emergency departments
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute Fever | Less than 7 days | Viral upper respiratory infections, influenza, gastroenteritis, urinary tract infection, pneumonia | Most common presentation; majority self-limited; focus on identifying serious bacterial infection |
| Subacute Fever | 7 to 21 days | Abscess formation, infective endocarditis, tuberculosis, infectious mononucleosis, cytomegalovirus | Warrants broader investigation; consider occult abscess, atypical infections, early autoimmune disease |
| Chronic or Prolonged Fever | Greater than 21 days | Tuberculosis, malignancy, connective tissue diseases, drug fever, factitious fever | Classic fever of unknown origin territory; systematic investigation required |
Classification by Temperature Height
| Grade | Temperature Range | Clinical Implications |
|---|---|---|
| Low-Grade Fever | 38.0°C to 38.9°C (100.4°F to 102°F) | Common in viral infections; less specific for etiology; often well-tolerated |
| Moderate Fever | 39.0°C to 39.9°C (102.2°F to 103.8°F) | May indicate bacterial infection; warrants closer evaluation; associated symptoms important |
| High-Grade Fever | 40.0°C to 41.0°C (104°F to 105.8°F) | Higher concern for serious bacterial infection; drug reactions; requires urgent evaluation |
| Hyperpyrexia | Greater than 41.1°C (greater than 106°F) | Medical emergency; consider central nervous system infection, drug-induced hyperthermia, heat stroke |
Classification by Pattern and Timing
| Pattern | Description | Classic Associations |
|---|---|---|
| Continuous (Sustained) | Temperature remains elevated with minimal variation (less than 1°C fluctuation) | Typhoid fever, drug fever, central nervous system disorders, gram-negative pneumonia |
| Remittent | Temperature fluctuates more than 1°C but does not return to normal | Most bacterial infections, infective endocarditis, viral infections |
| Intermittent (Quotidian) | Temperature returns to normal at least once daily | Abscess, lymphoma, miliary tuberculosis, pyogenic infections |
| Hectic (Septic) | Wide swings with high spikes and return to normal or subnormal, often with rigors | Pyogenic abscess, infective endocarditis, sepsis, pyelonephritis |
| Tertian | Fever spike every 48 hours (day 1, day 3, day 5) | Plasmodium vivax malaria, Plasmodium ovale malaria |
| Quartan | Fever spike every 72 hours (day 1, day 4, day 7) | Plasmodium malariae malaria |
| Pel-Ebstein | Recurrent episodes of fever lasting 1-2 weeks alternating with afebrile periods | Hodgkin lymphoma (rare but classic) |
| Relapsing | Febrile episodes separated by days to weeks of normal temperature | Borrelia infections, rat-bite fever, periodic fever syndromes |
Fever versus Hyperthermia
Fever (Pyrexia)
Mechanism: Regulated increase in hypothalamic set point mediated by pyrogens
Thermoregulation: Intact — body actively generates and conserves heat to reach new set point
Response to antipyretics: Temperature decreases
Upper limit: Rarely exceeds 41.1°C (106°F) due to negative feedback
Examples: Infection, inflammation, malignancy
Hyperthermia
Mechanism: Unregulated rise in temperature; hypothalamic set point is normal
Thermoregulation: Overwhelmed or impaired — heat gain exceeds heat dissipation capacity
Response to antipyretics: No effect
Upper limit: Can exceed 41.1°C (106°F); may be life-threatening
Examples: Heat stroke, malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome
Key Concept — The “Big Four” Categories of Fever Etiology:
- Infection — accounts for approximately 75-80% of acute fevers; bacterial, viral, fungal, and parasitic causes
- Malignancy — lymphoma, leukemia, renal cell carcinoma, hepatocellular carcinoma most commonly cause fever
- Autoimmune and Inflammatory Conditions — systemic lupus erythematosus, adult-onset Still disease, vasculitis, inflammatory bowel disease
- Miscellaneous — drug fever, venous thromboembolism, factitious fever, endocrine disorders (thyroid storm, adrenal crisis)
In fever of unknown origin, after thorough investigation: infections account for approximately 20-30%, malignancy 20-30%, autoimmune conditions 10-20%, and miscellaneous or undiagnosed 20-30%.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Fever
Fever is a complex, highly regulated physiological response that involves coordination between the immune system, the hypothalamus, and peripheral effector systems. Understanding the fever pathway helps clinicians appreciate why fever occurs, predict which conditions cause fever, and understand the rationale for therapeutic interventions. The febrile response has been conserved across evolution for over 400 million years, suggesting significant survival benefit.
The Fever Cascade
| Step | Component | Mechanism |
|---|---|---|
| Step 1: Trigger | Exogenous Pyrogens | External substances (bacterial lipopolysaccharide, viral particles, fungal components, toxins) enter the body and are recognized by immune cells |
| Step 2: Immune Activation | Monocytes, Macrophages, Neutrophils | Pattern recognition receptors (especially Toll-like receptors) on immune cells detect exogenous pyrogens and trigger cytokine release |
| Step 3: Endogenous Pyrogens | Pyrogenic Cytokines | Interleukin-1 (IL-1), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), and Interferons are released into circulation |
| Step 4: Central Processing | Organum Vasculosum of Lamina Terminalis (OVLT) | Pyrogenic cytokines act on this circumventricular organ (lacks blood-brain barrier) adjacent to the hypothalamus |
| Step 5: Prostaglandin Synthesis | Cyclooxygenase-2 (COX-2) pathway | Cytokines induce COX-2 in vascular endothelium and glial cells, leading to prostaglandin E2 (PGE2) production |
| Step 6: Set Point Elevation | Preoptic Hypothalamus | PGE2 binds to EP3 receptors on thermosensitive neurons, raising the thermoregulatory set point |
| Step 7: Effector Response | Autonomic and Behavioral | Vasoconstriction (heat conservation), shivering (heat generation), behavioral changes (seeking warmth, reduced activity) |
Key Pyrogenic Mediators and Their Roles
Interleukin-1 (IL-1)
Source: Monocytes, macrophages, dendritic cells
Pyrogenic effect: Potent endogenous pyrogen; acts directly on hypothalamus
Other effects: Induces acute phase response, activates T cells, promotes neutrophil recruitment
Clinical relevance: IL-1 receptor antagonist (anakinra) used in autoinflammatory syndromes
Interleukin-6 (IL-6)
Source: Macrophages, T cells, endothelial cells, fibroblasts
Pyrogenic effect: Major inducer of hepatic acute phase response; contributes to fever
Other effects: Stimulates C-reactive protein production, promotes B cell differentiation
Clinical relevance: Elevated in cytokine release syndrome; target for tocilizumab
Tumor Necrosis Factor-α (TNF-α)
Source: Macrophages, T cells, natural killer cells
Pyrogenic effect: Induces fever at low doses; at high doses may cause hypothermia in severe sepsis
Other effects: Activates vascular endothelium, promotes apoptosis, induces cachexia
Clinical relevance: Key mediator in septic shock; TNF inhibitors can unmask latent tuberculosis
Prostaglandin E2: The Final Common Pathway
Why Antipyretics Work: All conventional antipyretic medications (acetaminophen, aspirin, ibuprofen, naproxen) work by inhibiting cyclooxygenase enzymes, thereby blocking PGE2 synthesis. Since PGE2 is the final mediator that elevates the hypothalamic set point, blocking its production allows the set point to normalize.
- NSAIDs (ibuprofen, naproxen): Inhibit both COX-1 and COX-2 peripherally and centrally
- Aspirin: Irreversibly inhibits COX enzymes
- Acetaminophen: Primarily central COX inhibition; mechanism not fully understood; may involve endocannabinoid system
Clinical Implication: Antipyretics lower fever but do not treat the underlying cause. Response to antipyretics does NOT distinguish bacterial from viral infection.
How Different Conditions Cause Fever
| Condition Category | Mechanism of Fever | Clinical Implication |
|---|---|---|
| Bacterial Infection | Lipopolysaccharide (gram-negative) or lipoteichoic acid (gram-positive) activates Toll-like receptors on macrophages, triggering IL-1, IL-6, TNF-α release | Often high-grade fever with rigors; responds to antibiotics; may have leukocytosis |
| Viral Infection | Viral nucleic acids (RNA, DNA) activate Toll-like receptors 3, 7, 8, 9 and RIG-I receptors; interferon production is prominent | Often lower-grade fever; may have relative lymphocytosis; typically self-limited |
| Malignancy | Tumor cells directly produce pyrogenic cytokines (especially IL-6); tumor necrosis releases cellular contents; immune response to tumor antigens | May be only presenting sign; suspect in unexplained prolonged fever; lymphoma and leukemia most commonly cause fever |
| Autoimmune Disease | Immune complex deposition activates complement and macrophages; autoreactive T cells release pyrogenic cytokines; chronic inflammation | Often accompanies disease flare; may respond to corticosteroids or immunosuppressants rather than antipyretics alone |
| Drug Fever | Multiple mechanisms: hypersensitivity reactions (immune-mediated), direct pyrogenic effect, altered thermoregulation, idiosyncratic reactions | Diagnosis of exclusion; patient often appears well despite fever; eosinophilia may be present; resolves within 48-72 hours of drug discontinuation |
| Tissue Necrosis (Myocardial Infarction, Pulmonary Embolism, Stroke) | Dying cells release damage-associated molecular patterns (DAMPs) that activate innate immune receptors; inflammatory response to tissue damage | Low-grade fever common 24-48 hours after event; high fever suggests secondary infection |
| Transfusion Reaction | Antibodies against donor white blood cells or cytokines accumulated in stored blood products trigger recipient immune response | Fever during or shortly after transfusion; distinguish from hemolytic reaction (more severe, with hemoglobinuria) |
Benefits of Fever: Why the Body Generates Fever
Enhanced Immune Function
- Increased neutrophil and macrophage mobility and phagocytosis
- Enhanced T cell and B cell proliferation
- Increased interferon production and activity
- Improved antibody production
- Enhanced antigen presentation
Direct Antimicrobial Effects
- Many bacteria and viruses replicate optimally at 37°C; elevated temperature impairs growth
- Reduced iron availability (fever induces lactoferrin and hepcidin, sequestering iron from pathogens)
- Increased heat shock protein expression enhances cellular stress response
- Some antimicrobial enzymes have enhanced activity at elevated temperatures
Physiological Limits and Complications of Fever
| Temperature Range | Physiological Effects | Clinical Concerns |
|---|---|---|
| 38-39°C (100.4-102.2°F) | Increased metabolic rate (approximately 10-12% per 1°C), mild tachycardia, increased oxygen consumption | Generally well-tolerated in healthy adults; may cause discomfort |
| 39-40°C (102.2-104°F) | Significant increase in cardiac output, respiratory rate, and metabolic demands | May stress patients with limited cardiac or respiratory reserve; dehydration risk |
| 40-41°C (104-105.8°F) | Marked cardiovascular stress; may trigger febrile seizures in susceptible individuals; protein denaturation begins | Consider active cooling; high risk in elderly, cardiac patients; assess for hyperthermia syndromes |
| Greater than 41.1°C (greater than 106°F) | Risk of cellular damage, rhabdomyolysis, disseminated intravascular coagulation, multi-organ failure | Medical emergency; likely hyperthermia rather than fever; aggressive cooling and supportive care required |
Often Overlooked Mechanism: Hypothalamic Dysfunction and Absent Fever
Certain patient populations may have a blunted or absent febrile response despite serious infection:
- Elderly patients: Age-related decline in thermoregulatory capacity; may have “normal” temperature (37.5°C) that represents significant fever for them
- Chronic kidney disease: Uremia impairs cytokine production and hypothalamic response
- Corticosteroid use: Suppresses cytokine production and may mask fever
- Neonates and infants: Immature thermoregulation (not applicable to adult medicine but important to recognize)
- Severe sepsis: Hypothermia (temperature less than 36°C) may occur and carries worse prognosis than fever
Clinical Implication: In high-risk patients, absence of fever does NOT exclude serious infection. A temperature that might be “normal” in a young adult may represent significant fever in an elderly patient. Always consider the clinical context.
3. History Taking
A comprehensive approach to eliciting the Fever history
Red Flags — Require Urgent Evaluation
- Hemodynamic instability — hypotension, tachycardia, altered mental status (sepsis)
- Severe headache with neck stiffness — meningitis or subarachnoid hemorrhage
- Petechial or purpuric rash — meningococcemia, disseminated intravascular coagulation
- New heart murmur in febrile patient — infective endocarditis
- Immunocompromised state — HIV/AIDS, chemotherapy, transplant recipients, high-dose steroids
- Recent surgery or invasive procedure — surgical site infection, healthcare-associated infection
- Fever greater than 41°C (105.8°F) — hyperpyrexia, possible hyperthermia syndrome
- Hypothermia (less than 36°C) with suspected infection — severe sepsis, poor prognosis
- Rigors (true shaking chills) — bacteremia, abscess, pyelonephritis
- Return from endemic area with high fever — malaria, typhoid, dengue, viral hemorrhagic fever
Systematic History: The “FEVER” Approach
Use the mnemonic “FEVER” to ensure comprehensive history taking:
- F — Fever characteristics: Onset, duration, pattern, maximum temperature, response to antipyretics, associated rigors or night sweats
- E — Exposures and epidemiology: Sick contacts, travel history, animal exposures, occupational exposures, sexual history, intravenous drug use, recent hospitalization
- V — Vital associated symptoms: Systematic review focusing on localizing symptoms (cough, dysuria, headache, abdominal pain, rash, joint pain)
- E — Existing conditions and medications: Immunocompromising conditions, implanted devices, recent procedures, current medications (especially antibiotics, immunosuppressants)
- R — Red flags and risk factors: Warning signs requiring urgent evaluation, underlying conditions that increase risk of serious infection
Characterizing the Fever
| Question | Why It Matters | Clinical Significance |
|---|---|---|
| “When did the fever start?” | Determines acute versus chronic classification | Less than 7 days: likely infectious; greater than 3 weeks: fever of unknown origin workup |
| “How high has the temperature been?” | Higher temperatures may suggest bacterial infection | Greater than 39°C more concerning; greater than 41°C consider hyperthermia syndromes |
| “Is the fever constant or does it come and go?” | Pattern may suggest specific etiologies | Intermittent with rigors: bacteremia, abscess; periodic: malaria, cyclic neutropenia |
| “Do you have shaking chills (rigors)?” | True rigors suggest bacteremia | Rigors have positive predictive value of approximately 15-20% for bacteremia |
| “Do you have drenching night sweats?” | Suggests specific conditions | Tuberculosis, lymphoma, endocarditis, brucellosis |
| “Does the fever respond to acetaminophen or ibuprofen?” | Distinguishes fever from hyperthermia | Response does NOT distinguish bacterial from viral; no response suggests hyperthermia |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Upper respiratory tract infection | Rhinorrhea, sore throat, cough | “Do you have a runny nose, sore throat, or cough? Any sick contacts?” |
| Pneumonia | Productive cough, dyspnea, pleuritic chest pain | “Are you coughing up sputum? Do you feel short of breath? Any chest pain with breathing?” |
| Urinary tract infection or pyelonephritis | Dysuria, frequency, flank pain | “Do you have burning with urination? Are you urinating more frequently? Any back or flank pain?” |
| Intra-abdominal infection | Abdominal pain, nausea, vomiting, diarrhea | “Do you have abdominal pain? Where exactly? Any nausea, vomiting, or diarrhea?” |
| Skin or soft tissue infection | Localized redness, swelling, pain | “Do you have any areas of redness, swelling, or pain on your skin? Any wounds or recent injuries?” |
| Meningitis or encephalitis | Severe headache, photophobia, neck stiffness, altered consciousness | “Do you have a severe headache? Does light bother your eyes? Is your neck stiff? Any confusion?” |
| Infective endocarditis | Predisposing cardiac condition, intravenous drug use, prolonged fever | “Do you have a history of heart valve problems? Do you use intravenous drugs? Any recent dental work?” |
| Tuberculosis | Prolonged fever, night sweats, weight loss, chronic cough | “Have you lost weight unintentionally? Do you have drenching night sweats? Have you been exposed to tuberculosis?” |
| Malignancy | Weight loss, fatigue, lymphadenopathy, prolonged fever | “Have you noticed any lumps or swollen glands? Unintentional weight loss? Fatigue? Easy bruising?” |
| Autoimmune disease | Joint pain, rash, oral ulcers, multisystem involvement | “Do you have joint pain or swelling? Any rashes? Mouth sores? Hair loss?” |
| Drug fever | Recent medication change, relatively well-appearing patient | “Have you started any new medications in the past few weeks? Including over-the-counter or herbal supplements?” |
Critical Exposure History
| Exposure Type | Specific Questions | Consider These Diagnoses |
|---|---|---|
| Travel history | Where, when, activities, prophylaxis used, insect bites | Malaria (Africa, Asia), typhoid (South Asia), dengue (tropics), histoplasmosis (Mississippi/Ohio River valleys) |
| Animal contact | Pets, farm animals, wild animals, bites, scratches | Cat scratch disease, Q fever (farm animals), leptospirosis (rodent urine), psittacosis (birds) |
| Tick or insect exposure | Outdoor activities, known bites, geographic location | Lyme disease, Rocky Mountain spotted fever, ehrlichiosis, babesiosis |
| Sexual history | New partners, high-risk practices, HIV status | Acute HIV infection, gonococcal bacteremia, syphilis, viral hepatitis |
| Intravenous drug use | Injection practices, sharing equipment | Infective endocarditis, HIV, hepatitis B/C, skin and soft tissue infection, osteomyelitis |
| Healthcare exposure | Recent hospitalization, surgery, dialysis, indwelling devices | Healthcare-associated pneumonia, catheter-related bloodstream infection, surgical site infection, Clostridioides difficile |
| Food and water | Undercooked meat, unpasteurized dairy, contaminated water | Salmonella, Campylobacter, Listeria, hepatitis A, parasitic infections |
| Occupational | Healthcare work, veterinary work, farming, laboratory work | Tuberculosis (healthcare), brucellosis (veterinary), Q fever (farming), specific laboratory exposures |
Medication and Social History
Medications That Commonly Cause Fever
- Antibiotics — beta-lactams (especially ampicillin), sulfonamides, nitrofurantoin, vancomycin
- Anticonvulsants — phenytoin, carbamazepine, lamotrigine (may cause Drug Reaction with Eosinophilia and Systemic Symptoms)
- Cardiovascular drugs — procainamide, quinidine, hydralazine, methyldopa
- Allopurinol — can cause severe hypersensitivity syndrome
- Antipsychotics — may cause neuroleptic malignant syndrome
- Serotonergic drugs — SSRIs, SNRIs, MAOIs may cause serotonin syndrome
- Interferons and biological agents — direct pyrogenic effect
- Chemotherapy agents — direct effect or secondary to neutropenia
Social History Elements
- Living situation: Homeless, shelter residence, crowded housing (tuberculosis risk)
- Incarceration history: Higher rates of tuberculosis, HIV, hepatitis
- Alcohol use: Aspiration pneumonia, spontaneous bacterial peritonitis in cirrhosis
- Tobacco use: Community-acquired pneumonia, malignancy
- Immigration history: Tuberculosis, parasitic infections endemic to country of origin
- Sick contacts: Recent illness in household members, coworkers, school contacts
- Vaccination status: Influenza, pneumococcal, COVID-19, hepatitis B
Special Considerations in Immunocompromised Patients
Always assess immune status, as this dramatically changes the differential diagnosis:
- HIV/AIDS: CD4 count determines opportunistic infection risk; ask about adherence to antiretroviral therapy
- Neutropenia: Chemotherapy timing, absolute neutrophil count; fever may be only sign of severe infection
- Solid organ transplant: Time since transplant, immunosuppressive regimen, cytomegalovirus status
- Corticosteroid use: Dose and duration (greater than 20 mg prednisone daily for greater than 2 weeks significant)
- Biological agents: TNF inhibitors reactivate tuberculosis; rituximab causes hypogammaglobulinemia
- Asplenia: High risk for encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis)
4. Physical Examination
A systematic head-to-toe approach for Fever
Systematic Framework: Use the “Head to Extremities” approach for complete examination of patients presenting with fever. The goal is to identify the source of infection and assess severity. Remember that a thorough examination may reveal the diagnosis in up to 25% of patients with fever of unknown origin.
General Inspection
- Appearance: Well versus ill-appearing; toxic appearance suggests serious infection
- Level of consciousness: Alert, confused, lethargic, obtunded — altered mental status is a red flag
- Respiratory effort: Tachypnea, use of accessory muscles, nasal flaring
- Color: Pallor (anemia, poor perfusion), flushing (fever), cyanosis (hypoxia), jaundice (hepatobiliary disease)
- Diaphoresis: May indicate defervescence, severe infection, or hyperthermia
- Cachexia: Suggests chronic illness, malignancy, or chronic infection
- Rigors: Visible shaking chills strongly suggest bacteremia
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Document method (oral, tympanic, rectal); rectal most accurate; note hypothermia as well as fever | Greater than 38.0°C confirms fever; hypothermia (less than 36°C) in infection indicates poor prognosis; elderly may have blunted response |
| Heart Rate | Expected increase of approximately 10 beats per minute per 1°C rise in temperature | Relative bradycardia (pulse-temperature dissociation) suggests typhoid, brucellosis, Legionella, drug fever, factitious fever |
| Blood Pressure | Hypotension (systolic less than 90 mmHg or drop greater than 40 mmHg from baseline) | Hypotension indicates septic shock — requires immediate resuscitation; widened pulse pressure in early sepsis |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute in adults) | May indicate pulmonary infection, metabolic acidosis (compensation), or respiratory distress; part of qSOFA score |
| Oxygen Saturation | Hypoxemia (SpO2 less than 94% on room air) | Suggests pulmonary involvement; may be normal in early pneumonia; does not detect hypercapnia |
Quick Sepsis Assessment (qSOFA)
In patients with suspected infection, qSOFA score ≥2 indicates high risk of poor outcome:
- Respiratory rate ≥22 breaths per minute (1 point)
- Altered mental status (Glasgow Coma Scale less than 15) (1 point)
- Systolic blood pressure ≤100 mmHg (1 point)
Score ≥2: Consider ICU-level care, aggressive resuscitation, and early antibiotics if sepsis suspected.
Head, Eyes, Ears, Nose, Throat, and Neck Examination
Head and Face
Sinuses: Tenderness over maxillary or frontal sinuses suggests sinusitis
Temporal arteries: Tenderness, decreased pulsation, nodularity in patients over 50 (giant cell arteritis)
Scalp: Look for signs of infection, temporal artery abnormalities
Eyes
Conjunctivae: Pallor (anemia), petechiae (endocarditis), injection (conjunctivitis, Kawasaki-like illness)
Sclera: Icterus (hepatobiliary disease, hemolysis)
Fundoscopy: Roth spots (white-centered retinal hemorrhages) in endocarditis; papilledema suggests increased intracranial pressure
Ears and Nose
Tympanic membranes: Erythema, bulging, effusion (otitis media)
External ear: Cellulitis, malignant otitis externa (diabetics)
Nasal mucosa: Erythema, discharge, septal perforation (granulomatosis with polyangiitis)
Oropharynx and Neck
Pharynx: Erythema, exudates, tonsillar enlargement (pharyngitis, peritonsillar abscess)
Oral mucosa: Ulcers (herpes, aphthous, systemic lupus erythematosus), thrush (immunocompromise), Koplik spots (measles)
Dentition: Dental abscess, poor dentition (endocarditis risk)
Neck: Meningismus (meningitis), lymphadenopathy, thyroid enlargement or tenderness (thyroiditis)
Lymph Node Examination
| Location | Drainage Area | Associated Conditions |
|---|---|---|
| Cervical | Head, neck, upper respiratory tract | Upper respiratory infection, pharyngitis, dental infection, lymphoma, tuberculosis |
| Supraclavicular | Thorax, abdomen (left side — Virchow node) | Malignancy (particularly left supraclavicular); always pathological — requires investigation |
| Axillary | Upper extremity, breast, chest wall | Local infection, cat scratch disease, breast cancer, lymphoma |
| Epitrochlear | Forearm, hand | Secondary syphilis, lymphoma, sarcoidosis; often overlooked |
| Inguinal | Lower extremity, genitalia, perineum | Sexually transmitted infections, cellulitis, lymphoma (if greater than 2 cm) |
| Generalized | Multiple non-contiguous regions | HIV, infectious mononucleosis, lymphoma, systemic lupus erythematosus, sarcoidosis |
Cardiovascular Examination
- Jugular venous pressure: Elevated in right heart failure, pericardial disease, volume overload
- Heart sounds: New murmur (especially regurgitant murmur) raises concern for infective endocarditis
- Pericardial rub: Three-component friction rub suggests pericarditis
- Peripheral pulses: Weak or absent pulses may indicate large vessel vasculitis or emboli
- Capillary refill: Prolonged (greater than 3 seconds) suggests poor perfusion
Peripheral Stigmata of Infective Endocarditis
- Splinter hemorrhages: Linear red-brown streaks under fingernails or toenails
- Janeway lesions: Painless erythematous macules on palms and soles
- Osler nodes: Painful, raised lesions on finger or toe pads
- Conjunctival or oral petechiae: Small hemorrhages
- Clubbing: May develop with subacute endocarditis
Note: These classic findings are present in fewer than 50% of cases. Absence does not exclude endocarditis.
Respiratory Examination
Inspection
- Respiratory rate and pattern — tachypnea, use of accessory muscles
- Chest wall deformity — kyphoscoliosis predisposes to pneumonia
- Surgical scars — recent thoracic surgery
Palpation
- Tracheal position — deviation suggests large effusion, pneumothorax, or collapse
- Chest expansion — asymmetric expansion suggests unilateral pathology
- Tactile fremitus — increased over consolidation, decreased over effusion
Percussion
- Dullness — consolidation (pneumonia), pleural effusion (parapneumonic effusion, empyema)
- Hyperresonance — pneumothorax, severe emphysema
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Bronchial breath sounds | Loud, high-pitched sounds heard over peripheral lung fields | Consolidation (pneumonia) |
| Crackles (rales) | Discontinuous sounds, fine or coarse | Pneumonia, pulmonary edema, interstitial lung disease |
| Wheezes | Continuous musical sounds, usually expiratory | Bronchospasm (asthma exacerbation triggered by infection), bronchitis |
| Pleural friction rub | Grating sound during inspiration and expiration | Pleuritis, pulmonary embolism with infarction, pneumonia with pleural involvement |
| Decreased breath sounds | Diminished or absent breath sounds | Pleural effusion, pneumothorax, lobar collapse |
| Egophony (E-to-A change) | “E” sounds like “A” over affected area | Consolidation, pleural effusion (at upper border) |
Abdominal Examination
- Inspection: Distension (ascites, obstruction), surgical scars, visible peristalsis
- Auscultation: Absent bowel sounds (ileus, peritonitis), hyperactive (gastroenteritis, obstruction)
- Palpation: Localized tenderness (appendicitis, cholecystitis, diverticulitis), guarding, rebound tenderness (peritonitis), hepatomegaly, splenomegaly
- Percussion: Shifting dullness (ascites), liver span, splenic enlargement
- Specific signs: Murphy sign (cholecystitis), McBurney point tenderness (appendicitis), Rovsing sign (appendicitis), costovertebral angle tenderness (pyelonephritis)
Hepatosplenomegaly with Fever
Hepatomegaly: Viral hepatitis, liver abscess, right heart failure, malignancy, amebic liver abscess
Splenomegaly: Infectious mononucleosis, endocarditis, malaria, typhoid, leukemia, lymphoma
Both (hepatosplenomegaly): Infectious mononucleosis, cytomegalovirus, HIV, leishmaniasis, brucellosis, lymphoproliferative disorders
Skin Examination
| Finding | Description | Associated Conditions |
|---|---|---|
| Petechiae | Non-blanching, less than 2 mm | Meningococcemia, endocarditis, thrombocytopenia, Rocky Mountain spotted fever |
| Purpura | Non-blanching, 2 mm to 1 cm | Disseminated intravascular coagulation, vasculitis, meningococcemia |
| Maculopapular rash | Flat and raised lesions, often blanching | Viral exanthem, drug reaction, secondary syphilis, acute HIV |
| Vesicles | Small fluid-filled blisters | Herpes simplex, varicella zoster, hand-foot-mouth disease |
| Erythema | Localized redness with warmth | Cellulitis, abscess, erysipelas, necrotizing fasciitis |
| Erythema nodosum | Painful, raised, red nodules on anterior shins | Sarcoidosis, tuberculosis, inflammatory bowel disease, streptococcal infection |
| Erythema migrans | Expanding erythematous ring, often with central clearing | Lyme disease (pathognomonic) |
| Eschar | Black necrotic lesion | Rickettsial infections, anthrax, ecthyma gangrenosum (Pseudomonas) |
Musculoskeletal and Neurological Examination
Musculoskeletal
- Joint examination: Swelling, warmth, erythema, effusion — septic arthritis is a medical emergency
- Spine: Point tenderness (osteomyelitis, epidural abscess, discitis)
- Muscle tenderness: Myositis, rhabdomyolysis
- Prosthetic joints: Higher suspicion for prosthetic joint infection
Neurological
- Mental status: Confusion, lethargy (encephalitis, meningitis, sepsis)
- Meningeal signs: Nuchal rigidity, Kernig sign, Brudzinski sign
- Focal deficits: May indicate brain abscess, stroke, or mass lesion
- Cranial nerves: Involvement suggests basilar meningitis (tuberculosis, Listeria)
Expected Findings by Etiology
| Condition | General Appearance | Key Physical Findings | Other Clues |
|---|---|---|---|
| Community-acquired pneumonia | May appear ill, tachypneic | Crackles, bronchial breath sounds, dullness to percussion, egophony | Productive cough, pleuritic chest pain |
| Urinary tract infection / Pyelonephritis | May be well or ill-appearing | Costovertebral angle tenderness, suprapubic tenderness | Dysuria, frequency, urgency |
| Cellulitis | Generally well unless systemic | Well-demarcated erythema, warmth, swelling, tenderness | Portal of entry (wound, tinea pedis) |
| Infective endocarditis | Variable; may appear well | New or changing murmur, splinter hemorrhages, Janeway lesions, splenomegaly | Predisposing cardiac condition, intravenous drug use |
| Meningitis | Ill-appearing, toxic | Nuchal rigidity, Kernig sign, Brudzinski sign, petechial rash (meningococcal) | Severe headache, photophobia, altered consciousness |
| Intra-abdominal abscess | Ill-appearing with sepsis | Localized abdominal tenderness, mass, guarding | Recent surgery, diverticulitis, appendicitis history |
| Drug fever | Often relatively well-appearing | May have rash; otherwise often normal examination | Relative bradycardia; recent medication change |
| Lymphoma | May have weight loss, fatigue | Lymphadenopathy (often painless), hepatosplenomegaly | Night sweats, pruritus, Pel-Ebstein fever pattern |
Important Teaching Point
Normal examination is common! Many causes of fever present with entirely normal physical examination findings, including:
- Viral syndromes: Often only fever without localizing signs
- Early bacterial infection: Physical signs may not develop for 24-48 hours
- Urinary tract infection: May have no findings beyond suprapubic or costovertebral angle tenderness
- Drug fever: Classic presentation is fever with otherwise normal examination
- Occult bacteremia: No localizing source despite bloodstream infection
- Early endocarditis: Murmur may not be present initially
A normal examination does NOT exclude serious bacterial infection. Clinical judgment, risk factors, and ancillary testing remain essential.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Fever (Duration: Less than 7 days)
The vast majority of acute febrile illnesses in immunocompetent adults are caused by self-limited viral infections. However, the clinician must identify the minority with serious bacterial infection requiring specific treatment.
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70-80%) | Viral upper respiratory tract infection | Rhinorrhea, sore throat, cough, myalgias, low-grade fever | Usually none; prolonged symptoms suggest bacterial superinfection |
| Influenza | Abrupt onset, high fever, severe myalgias, headache, dry cough | Dyspnea, hypoxia (pneumonia); altered mental status in elderly | |
| Acute gastroenteritis | Nausea, vomiting, diarrhea, abdominal cramps, low-grade fever | Bloody diarrhea, severe dehydration, high fever (invasive pathogen) | |
| Urinary tract infection | Dysuria, frequency, urgency, suprapubic discomfort | Flank pain, high fever, rigors (pyelonephritis) | |
| Acute bronchitis | Cough (often productive), low-grade fever, chest discomfort | Dyspnea, hypoxia, focal lung findings (pneumonia) | |
| LESS COMMON (approximately 15-20%) | Community-acquired pneumonia | Productive cough, dyspnea, pleuritic chest pain, fever | Hypoxia, hypotension, altered mental status, multilobar involvement |
| Pyelonephritis | Flank pain, high fever, rigors, nausea, costovertebral angle tenderness | Sepsis, obstruction (hydronephrosis), abscess formation | |
| Cellulitis | Localized erythema, warmth, swelling, tenderness; portal of entry | Rapid progression, crepitus, bullae, necrosis (necrotizing fasciitis) | |
| Acute sinusitis (bacterial) | Facial pain, purulent nasal discharge, symptoms greater than 10 days or biphasic | Periorbital edema, vision changes, severe headache (complications) | |
| Intra-abdominal infection | Abdominal pain, localized tenderness, fever; appendicitis, cholecystitis, diverticulitis | Peritoneal signs, rigidity, sepsis | |
| UNCOMMON BUT SERIOUS (approximately 5-10%) | Bacterial meningitis | Severe headache, neck stiffness, photophobia, altered consciousness | Petechial rash, seizures, focal deficits, rapid deterioration |
| Infective endocarditis | Prolonged fever, new murmur, risk factors (valve disease, intravenous drug use) | Embolic phenomena, heart failure, septic shock | |
| Sepsis / Bacteremia | High fever, rigors, tachycardia, may have identifiable source or occult | Hypotension, altered mental status, organ dysfunction | |
| Necrotizing fasciitis | Pain out of proportion, rapidly spreading erythema, systemic toxicity | Crepitus, bullae, skin necrosis, hemodynamic instability | |
| Epidural abscess | Back pain, fever, neurological deficits; risk factors (diabetes, intravenous drug use) | Progressive weakness, bowel/bladder dysfunction (emergency) |
Subacute Fever (Duration: 7 to 21 days)
Clinical Approach to Subacute Fever:
- Step 1: Reassess for common causes that may have been missed — Has pneumonia developed? Occult urinary tract infection? Drug fever?
- Step 2: Consider infections requiring longer incubation or slower progression — Endocarditis, tuberculosis, abscess, mononucleosis
- Step 3: Expand differential to include non-infectious causes — Malignancy, autoimmune disease
| Category | Condition | Key Features | Diagnostic Clues |
|---|---|---|---|
| Infectious | Infective endocarditis | Subacute onset, cardiac risk factors, embolic events | New murmur, positive blood cultures, vegetations on echocardiogram |
| Occult abscess | Hectic fever pattern, recent surgery or procedure, localized pain | Imaging (CT, MRI) reveals collection; blood cultures may be positive | |
| Infectious mononucleosis | Sore throat, fatigue, lymphadenopathy, splenomegaly; young adults | Atypical lymphocytosis, positive heterophile or Epstein-Barr virus serology | |
| Tuberculosis | Night sweats, weight loss, chronic cough, risk factors | Chest radiograph abnormalities, positive tuberculin skin test or interferon-gamma release assay | |
| Malignancy | Lymphoma | Painless lymphadenopathy, night sweats, weight loss, pruritus | Lymph node biopsy, imaging showing adenopathy |
| Leukemia | Fatigue, bleeding, infections, hepatosplenomegaly | Abnormal complete blood count, peripheral smear, bone marrow biopsy | |
| Inflammatory | Adult-onset Still disease | Quotidian fever, evanescent salmon-colored rash, arthritis, sore throat | Very high ferritin, leukocytosis, negative rheumatoid factor and antinuclear antibody |
| Systemic lupus erythematosus flare | Multisystem involvement, rash, arthritis, serositis | Positive antinuclear antibody, anti-double stranded DNA, complement levels |
Chronic Fever and Fever of Unknown Origin (Duration: Greater than 3 weeks)
Classic Definition of Fever of Unknown Origin
Fever of unknown origin is defined as:
- Temperature greater than 38.3°C (101°F) on multiple occasions
- Duration greater than 3 weeks
- No diagnosis after 1 week of inpatient investigation OR three outpatient visits
Modern studies show that with thorough investigation, a diagnosis is established in approximately 90% of cases.
| Category | Approximate Frequency | Conditions | Key Diagnostic Approaches |
|---|---|---|---|
| Infections | 20-30% | Tuberculosis, endocarditis, occult abscess (dental, intra-abdominal, pelvic), osteomyelitis, cytomegalovirus, Epstein-Barr virus, HIV | Cultures, serologies, imaging (CT, PET-CT), echocardiography |
| Malignancy | 20-30% | Lymphoma (especially non-Hodgkin), leukemia, renal cell carcinoma, hepatocellular carcinoma, atrial myxoma | CT chest/abdomen/pelvis, PET-CT, tissue biopsy, tumor markers |
| Autoimmune and Inflammatory | 10-20% | Adult-onset Still disease, systemic lupus erythematosus, vasculitis (giant cell arteritis, polyarteritis nodosa), inflammatory bowel disease, sarcoidosis | Autoantibodies, inflammatory markers, tissue biopsy, temporal artery biopsy in elderly |
| Miscellaneous | 10-15% | Drug fever, venous thromboembolism, thyroiditis, adrenal insufficiency, factitious fever | Medication review, Doppler ultrasound/CT angiography, thyroid function, cortisol level |
| Undiagnosed | 10-20% | Despite thorough investigation; often self-resolving; may be viral or occult autoimmune | Close follow-up; often resolves spontaneously; prognosis generally good |
Anatomical Approach to Fever Source
Head and Neck
Meningitis, encephalitis
Sinusitis
Pharyngitis, peritonsillar abscess
Otitis media, mastoiditis
Dental abscess
Thyroiditis
Temporal arteritis
Thorax
Pneumonia, lung abscess
Empyema
Infective endocarditis
Pericarditis, myocarditis
Mediastinitis
Pulmonary embolism
Tuberculosis
Abdomen and Pelvis
Cholecystitis, cholangitis
Liver abscess, hepatitis
Appendicitis, diverticulitis
Intra-abdominal abscess
Pyelonephritis, perinephric abscess
Pelvic inflammatory disease
Prostatitis
Musculoskeletal and Skin
Cellulitis, erysipelas
Necrotizing fasciitis
Septic arthritis
Osteomyelitis
Epidural abscess
Discitis
Infected prosthesis
Drug-Induced Fever
Drug fever should be suspected in any patient with unexplained fever who is taking medications, particularly if the patient appears relatively well despite elevated temperature. Fever typically occurs 7-10 days after starting a new medication but can occur at any time.
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-lactam antibiotics | Hypersensitivity reaction | May have rash, eosinophilia; often occurs after several days of therapy | 48-72 hours |
| Sulfonamides | Hypersensitivity, may cause Drug Reaction with Eosinophilia and Systemic Symptoms | Rash common, may have hepatitis, lymphadenopathy | 48-72 hours; longer if Drug Reaction with Eosinophilia and Systemic Symptoms |
| Anticonvulsants (phenytoin, carbamazepine) | Hypersensitivity, Drug Reaction with Eosinophilia and Systemic Symptoms | Rash, lymphadenopathy, hepatitis, eosinophilia | Days to weeks |
| Allopurinol | Hypersensitivity syndrome | Severe rash, hepatitis, renal failure, eosinophilia | Weeks; may be severe |
| Antipsychotics (haloperidol, typical antipsychotics) | Neuroleptic malignant syndrome | High fever, rigidity, altered consciousness, autonomic instability | 1-2 weeks; requires specific treatment |
| Serotonergic agents (SSRIs, SNRIs, MAOIs) | Serotonin syndrome | Fever, agitation, tremor, myoclonus, hyperreflexia, diarrhea | 24-72 hours with supportive care |
| Amphotericin B | Direct pyrogenic effect | Fever and rigors during infusion | Hours after infusion ends |
| Bleomycin | Direct effect and hypersensitivity | Fever common; may be severe | Variable |
| Interferons | Direct induction of pyrogenic cytokines | Fever, myalgias, flu-like symptoms; predictable | Hours after each dose |
| Procainamide, hydralazine | Drug-induced lupus | Fever, arthritis, serositis, positive antihistone antibodies | Weeks to months |
| Heparin | Unknown; possibly immune-mediated | Low-grade fever; consider heparin-induced thrombocytopenia if platelets drop | 48-72 hours |
| Vancomycin | Hypersensitivity | May have “red man syndrome,” rash, eosinophilia | 48-72 hours |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Fever + rigors + hypotension | Sepsis, bacteremia | Blood cultures, lactate, broad-spectrum antibiotics, fluid resuscitation |
| Fever + severe headache + neck stiffness | Bacterial meningitis | Lumbar puncture (if safe), empiric antibiotics immediately |
| Fever + petechial rash | Meningococcemia, Rocky Mountain spotted fever | Blood cultures, empiric antibiotics, do not delay for testing |
| Fever + new heart murmur | Infective endocarditis | Blood cultures (3 sets), echocardiography (transesophageal if high suspicion) |
| Fever + flank pain + costovertebral angle tenderness | Pyelonephritis | Urinalysis, urine culture, consider imaging if no response to treatment |
| Fever + cough + focal lung findings | Pneumonia | Chest radiograph, sputum culture, blood cultures if severe |
| Fever + recent travel to endemic area | Malaria, typhoid, dengue | Thick and thin blood smears, blood cultures, dengue serology |
| Fever + relative bradycardia | Typhoid, drug fever, Legionella, factitious fever | Blood cultures, Legionella urinary antigen, medication review |
| Fever + lymphadenopathy + splenomegaly | Infectious mononucleosis, lymphoma, HIV | Complete blood count, Epstein-Barr virus serology, HIV test |
| Fever + night sweats + weight loss | Tuberculosis, lymphoma, endocarditis | Chest radiograph, CT imaging, blood cultures, tuberculin skin test |
| Fever + back pain + neurological symptoms | Epidural abscess, vertebral osteomyelitis | Urgent MRI spine, blood cultures, neurosurgical consultation |
| Fever + joint swelling (single hot joint) | Septic arthritis | Urgent joint aspiration, synovial fluid analysis, blood cultures |
| Fever + rapidly spreading erythema + pain out of proportion | Necrotizing fasciitis | Urgent surgical consultation, broad-spectrum antibiotics, imaging |
| Fever + well-appearing patient + recent new medication | Drug fever | Medication review, discontinue suspected drug, observe for defervescence |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of fever should be guided by clinical findings from the history and physical examination. A targeted approach based on suspected etiology is more efficient and cost-effective than an exhaustive “shotgun” workup. However, certain baseline investigations are appropriate for most patients with significant fever.
Baseline Investigations for All Patients with Significant Fever
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count with differential | Assess for infection, inflammation, malignancy | Leukocytosis (bacterial), leukopenia (viral, overwhelming sepsis), left shift (bands greater than 10%), lymphocytosis (viral), eosinophilia (drug reaction, parasites), thrombocytopenia (sepsis, viral) | Normal white blood cell count does not exclude infection; elderly and immunocompromised may not mount leukocytosis |
| Basic metabolic panel | Assess hydration, renal function, electrolytes | Elevated creatinine (dehydration, sepsis), electrolyte abnormalities, elevated anion gap (lactic acidosis in sepsis) | Acute kidney injury in setting of fever suggests sepsis or volume depletion |
| Liver function tests | Screen for hepatobiliary infection, infiltrative disease | Elevated transaminases (hepatitis, liver abscess), elevated alkaline phosphatase (cholangitis, infiltrative disease), elevated bilirubin | May be mildly elevated in sepsis from any source (“shock liver”) |
| Urinalysis | Screen for urinary tract infection | Pyuria (greater than 10 white blood cells per high-power field), bacteriuria, nitrites, leukocyte esterase | May be negative in early pyelonephritis; obtain culture if any abnormality |
| Blood cultures (2 sets from different sites) | Detect bacteremia | Organism identification, antibiotic sensitivities | Obtain BEFORE antibiotics if possible; each set from separate venipuncture; hold for 5 days minimum |
| Chest radiograph | Screen for pneumonia, tuberculosis, malignancy | Infiltrates, consolidation, effusion, masses, lymphadenopathy | May be normal in early pneumonia, immunocompromised patients, or dehydrated patients; repeat if high suspicion |
| C-reactive protein and/or erythrocyte sedimentation rate | Assess degree of inflammation | C-reactive protein greater than 100 mg/L suggests bacterial infection; trends useful for monitoring | Non-specific; more useful for trending than single values; procalcitonin more specific for bacterial infection |
| Procalcitonin | Help differentiate bacterial from viral infection | Greater than 0.5 ng/mL suggests bacterial infection; greater than 2 ng/mL high probability of sepsis | Not elevated in viral infections or autoimmune disease; useful for antibiotic stewardship |
| Lactate | Assess tissue perfusion, screen for sepsis | Greater than 2 mmol/L suggests tissue hypoperfusion; greater than 4 mmol/L high mortality | Part of Sepsis-3 criteria; serial measurements guide resuscitation |
Targeted Investigations by Suspected Etiology
If Suspecting Respiratory Infection
First-Line Tests
- Chest radiograph: Infiltrate pattern (lobar, interstitial, multifocal) guides differential
- Sputum Gram stain and culture: If productive cough; obtain before antibiotics
- Respiratory viral panel: PCR for influenza, respiratory syncytial virus, COVID-19, other respiratory viruses
- Legionella urinary antigen: Detects serogroup 1 (most common); sensitivity approximately 70-80%
- Streptococcus pneumoniae urinary antigen: Rapid diagnosis; remains positive despite antibiotics
Second-Line Tests
- CT chest: If chest radiograph negative but high suspicion; better for abscess, empyema, tuberculosis
- Bronchoscopy with bronchoalveolar lavage: Immunocompromised patients, non-resolving pneumonia, suspected tuberculosis
- Thoracentesis: If pleural effusion present; analyze for empyema
- Sputum for acid-fast bacilli: If tuberculosis suspected; three morning samples
If Suspecting Urinary Tract Infection or Pyelonephritis
First-Line Tests
- Urinalysis: Pyuria, bacteriuria, nitrites (gram-negative bacteria), leukocyte esterase
- Urine culture: Greater than 100,000 colony-forming units per mL significant; lower counts may be significant in symptomatic patients
- Blood cultures: Obtain if pyelonephritis suspected; positive in approximately 20-30%
Second-Line Tests
- Renal ultrasound: If no response to appropriate antibiotics within 48-72 hours; look for obstruction, abscess
- CT abdomen and pelvis with contrast: If abscess suspected, or complicated urinary tract infection
- Post-void residual: If retention suspected as contributing factor
If Suspecting Intra-Abdominal Infection
First-Line Tests
- Liver function tests: Elevated alkaline phosphatase and bilirubin suggest biliary disease
- Lipase: If pancreatitis suspected
- Abdominal radiograph: Free air (perforation), obstruction pattern, fecalith
- Right upper quadrant ultrasound: First-line for cholecystitis, biliary dilation
Second-Line Tests
- CT abdomen and pelvis with contrast: Most useful for appendicitis, diverticulitis, abscess, obstruction
- Hepatobiliary iminodiacetic acid scan: If ultrasound equivocal for cholecystitis
- Magnetic resonance cholangiopancreatography or endoscopic retrograde cholangiopancreatography: If choledocholithiasis or cholangitis suspected
- Paracentesis: If ascites present; rule out spontaneous bacterial peritonitis
If Suspecting Infective Endocarditis
First-Line Tests
- Blood cultures: 3 sets from different sites over 24 hours; hold for extended incubation if HACEK organisms suspected
- Transthoracic echocardiography: First-line; sensitivity approximately 60-75% for vegetations
- Complete blood count: Anemia of chronic disease, elevated white blood cell count
- Urinalysis: Microscopic hematuria (emboli), red blood cell casts (glomerulonephritis)
Second-Line Tests
- Transesophageal echocardiography: Sensitivity greater than 90%; required if transthoracic echocardiography negative but clinical suspicion high; better for prosthetic valves, abscesses
- Rheumatoid factor: May be positive in subacute endocarditis
- CT or MRI: To detect embolic complications (stroke, splenic infarct, mycotic aneurysm)
- PET-CT: Increasingly used for prosthetic valve endocarditis
If Suspecting Central Nervous System Infection
First-Line Tests
- Lumbar puncture: Opening pressure, cell count, protein, glucose, Gram stain, culture
- CT head (before lumbar puncture if): Immunocompromised, history of central nervous system disease, new seizure, papilledema, focal neurological deficit, altered consciousness
- Blood cultures: Obtain before lumbar puncture and antibiotics
Second-Line Tests
- Cerebrospinal fluid PCR panel: Herpes simplex virus, enterovirus, West Nile virus, others
- Cerebrospinal fluid cryptococcal antigen: In immunocompromised patients
- MRI brain with contrast: If encephalitis or abscess suspected
- Electroencephalogram: If encephalitis suspected; may show temporal lobe abnormalities in herpes simplex virus encephalitis
Systematic Workup for Fever of Unknown Origin
Staged Approach to Fever of Unknown Origin:
- Stage 1 — Review and Repeat: Thorough history review (medications, travel, exposures), repeat physical examination, repeat baseline labs
- Stage 2 — Broad Screening: CT chest/abdomen/pelvis, echocardiography, tuberculin skin test, HIV test, autoimmune panel
- Stage 3 — Specialized Testing: PET-CT (increasingly first-line), temporal artery biopsy (if over 50), bone marrow biopsy, tissue biopsy of abnormalities
- Stage 4 — Watchful Waiting or Empiric Trials: If all investigations negative and patient stable
| Investigation | What It Detects | When to Order | Diagnostic Yield |
|---|---|---|---|
| CT chest, abdomen, pelvis with contrast | Occult abscess, lymphadenopathy, masses, organomegaly | Early in fever of unknown origin workup | Identifies source in approximately 20-30% of cases |
| PET-CT (fluorodeoxyglucose) | Metabolically active foci (infection, inflammation, malignancy) | Increasingly used early; especially useful when CT unrevealing | Identifies source in approximately 40-70% of cases; high sensitivity but limited specificity |
| Echocardiography (transesophageal if indicated) | Vegetations, valve abnormalities, atrial myxoma | All patients with fever of unknown origin; transesophageal if clinical suspicion high | Detects endocarditis in approximately 5-10% of fever of unknown origin cases |
| Temporal artery biopsy | Giant cell arteritis | Patients over 50 years with elevated erythrocyte sedimentation rate, headache, or visual symptoms | Giant cell arteritis accounts for approximately 15-20% of fever of unknown origin in elderly |
| Bone marrow biopsy | Hematologic malignancy, granulomatous disease, hemophagocytic syndrome | Cytopenias, suspected hematologic malignancy, or when other workup unrevealing | Diagnostic in approximately 5-15% of fever of unknown origin cases |
| Liver biopsy | Granulomatous hepatitis, lymphoma, miliary tuberculosis | Abnormal liver tests, hepatomegaly, or suspected granulomatous disease | Diagnostic in approximately 10-15% when targeted to abnormal findings |
| Autoimmune panel (antinuclear antibody, rheumatoid factor, antineutrophil cytoplasmic antibodies, complement levels) | Systemic lupus erythematosus, vasculitis, other autoimmune conditions | All fever of unknown origin patients; especially if arthritis, rash, or multisystem involvement | Autoimmune conditions account for approximately 10-20% of fever of unknown origin |
| Ferritin level | Adult-onset Still disease, hemophagocytic syndrome | Quotidian fever, rash, arthritis, or cytopenias | Very high ferritin (greater than 10,000 ng/mL) highly suggestive of hemophagocytic syndrome or Still disease |
Empiric Treatment Trials as Diagnostic Tools
When to Consider Empiric Therapy
Empiric treatment trials can serve as diagnostic tools when specific diagnoses cannot be confirmed but clinical suspicion is high. Response to therapy supports the diagnosis, but lack of response does not always exclude it.
- Empiric anti-tuberculosis therapy: If high clinical suspicion (endemic area, risk factors, compatible imaging) despite negative initial testing; response within 2-3 weeks supports diagnosis
- Empiric corticosteroids: If adult-onset Still disease or temporal arteritis strongly suspected; dramatic response within 48-72 hours; use cautiously as may mask infection
- Empiric doxycycline: If rickettsial disease, ehrlichiosis, or Q fever suspected (tick exposure, endemic area); rapid response expected
- Naproxen test: Historically used — fever due to malignancy (especially lymphoma) may respond to naproxen while infectious fever persists; limited utility and not widely recommended
Caution: Empiric therapy should not replace thorough diagnostic evaluation. Document rationale and establish clear endpoints for assessing response.
Investigation Priorities in Special Populations
| Population | Key Considerations | Priority Investigations |
|---|---|---|
| Neutropenic fever (absolute neutrophil count less than 500) | High mortality risk; urgent evaluation; empiric antibiotics within 1 hour | Blood cultures (central and peripheral), urine culture, chest radiograph, consider fungal markers (galactomannan, beta-D-glucan) if prolonged neutropenia |
| HIV/AIDS (CD4 less than 200) | Opportunistic infections; may have multiple concurrent infections | CD4 count, viral load, chest radiograph, cryptococcal antigen, toxoplasma serology, cytomegalovirus PCR, consider bronchoscopy for Pneumocystis jirovecii pneumonia |
| Post-transplant | Risk depends on time since transplant; rejection versus infection | Cytomegalovirus PCR, Epstein-Barr virus PCR, consider tissue biopsy for rejection versus infection |
| Returning traveler | Geography determines differential; incubation periods important | Malaria smears (thick and thin), blood cultures, stool studies, dengue serology, specific testing based on travel destination |
| Healthcare-associated fever | Device-related infections, resistant organisms, Clostridioides difficile | Line cultures, urine culture, Clostridioides difficile testing, chest radiograph, consider CT if intra-abdominal source suspected |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
The first priority when evaluating a febrile patient is to identify those requiring immediate intervention. Use clinical assessment and vital signs to stratify urgency.
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fever + hypotension (systolic blood pressure less than 90 mmHg) + altered mental status | EMERGENT | Activate sepsis protocol; IV access, fluid bolus, blood cultures, lactate, broad-spectrum antibiotics within 1 hour; consider ICU |
| Fever + petechial or purpuric rash | EMERGENT | Suspect meningococcemia; blood cultures, empiric antibiotics immediately (do not delay for lumbar puncture); contact isolation |
| Fever + severe headache + neck stiffness | EMERGENT | Suspect bacterial meningitis; CT head if indicated, lumbar puncture, empiric antibiotics within 1 hour; dexamethasone before or with antibiotics |
| Fever + rapidly progressive skin erythema + pain out of proportion | EMERGENT | Suspect necrotizing fasciitis; urgent surgical consultation, broad-spectrum antibiotics, prepare for operative debridement |
| Neutropenic fever (absolute neutrophil count less than 500) | EMERGENT | Blood cultures, empiric broad-spectrum antibiotics within 1 hour (antipseudomonal beta-lactam); admission for monitoring |
| Fever + new neurological deficits + back pain | EMERGENT | Suspect epidural abscess; urgent MRI spine, neurosurgical consultation, empiric antibiotics |
| Fever + single hot swollen joint | URGENT | Suspect septic arthritis; urgent joint aspiration before antibiotics, synovial fluid analysis, orthopedic consultation |
| Fever + rigors + flank pain | URGENT | Suspect pyelonephritis; urinalysis, urine culture, blood cultures, IV antibiotics, consider imaging for obstruction |
| Fever + dyspnea + hypoxia | URGENT | Chest radiograph, blood cultures, sputum culture, initiate appropriate antibiotic therapy; assess need for supplemental oxygen or respiratory support |
| Fever + abdominal pain + peritoneal signs | URGENT | Surgical consultation, CT abdomen, blood cultures, IV antibiotics; nil per os, IV fluids |
| Fever + recent travel to malaria-endemic area | URGENT | Thick and thin blood smears immediately (repeat every 12 hours if negative); empiric treatment if high suspicion and delay in results |
| Low-grade fever + upper respiratory symptoms + stable vital signs | ROUTINE | Symptomatic management, hydration, antipyretics; return precautions for worsening symptoms |
| Fever + well-appearing + no localizing signs | ROUTINE | Baseline investigations, close follow-up; consider outpatient management if reliable patient with good access to care |
Sepsis Recognition: The “Hour-1 Bundle”
For patients with suspected sepsis or septic shock, the Surviving Sepsis Campaign recommends completing within 1 hour:
- Measure lactate level — remeasure if initial lactate greater than 2 mmol/L
- Obtain blood cultures — before antibiotics, but do not delay antibiotics
- Administer broad-spectrum antibiotics — appropriate to suspected source
- Begin rapid fluid resuscitation — 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L
- Apply vasopressors — if hypotensive during or after fluid resuscitation to maintain mean arterial pressure ≥65 mmHg
Step 2: Classify by Duration
Acute (Less than 7 days)
Most likely: Viral infection, bacterial infection with identifiable source
Approach: Focus on identifying source and ruling out serious bacterial infection
Proceed to Algorithm A
Subacute (7 to 21 days)
Most likely: Prolonged viral syndrome, endocarditis, abscess, atypical infection
Approach: Broader investigation; consider conditions with longer incubation
Proceed to Algorithm B
Chronic (Greater than 21 days)
Most likely: Fever of unknown origin territory — infection, malignancy, autoimmune
Approach: Systematic fever of unknown origin workup
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Fever (Less than 7 days)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Upper respiratory symptoms (rhinorrhea, sore throat, cough) + low-grade fever + well-appearing | Viral upper respiratory tract infection | Symptomatic treatment; no antibiotics; return precautions |
| Abrupt onset + high fever + severe myalgias + dry cough during influenza season | Influenza | Rapid influenza test; oseltamivir if within 48 hours or high-risk patient; supportive care |
| Dysuria + frequency + suprapubic discomfort + low-grade fever | Lower urinary tract infection | Urinalysis, urine culture; oral antibiotics; consider pyelonephritis if systemic symptoms |
| Productive cough + dyspnea + focal lung findings + fever | Community-acquired pneumonia | Chest radiograph; stratify severity (CURB-65 or Pneumonia Severity Index); appropriate antibiotics; admission if severe |
| Right upper quadrant pain + fever + Murphy sign positive | Acute cholecystitis | Right upper quadrant ultrasound; surgical consultation; IV antibiotics; plan for cholecystectomy |
| Right lower quadrant pain + fever + anorexia + migration of pain | Acute appendicitis | CT abdomen; surgical consultation; IV antibiotics; appendectomy |
| Localized erythema + warmth + swelling + portal of entry | Cellulitis | Mark borders; oral or IV antibiotics based on severity; elevation; close follow-up |
| Fever + no localizing symptoms + well-appearing + normal examination | Viral syndrome versus early bacterial infection | Baseline labs, urinalysis, chest radiograph; close follow-up in 24-48 hours; return precautions |
Algorithm B: Subacute Fever (7 to 21 days)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Prolonged fever + cardiac risk factors (valve disease, intravenous drug use) + embolic events | Infective endocarditis | Three sets of blood cultures; echocardiography (transesophageal if high suspicion); apply modified Duke criteria |
| Fever + severe fatigue + pharyngitis + lymphadenopathy + splenomegaly in young adult | Infectious mononucleosis | Complete blood count (atypical lymphocytes); heterophile antibody or Epstein-Barr virus serology; supportive care; avoid contact sports |
| Fever + night sweats + weight loss + chronic cough + risk factors | Pulmonary tuberculosis | Chest radiograph; sputum for acid-fast bacilli smear and culture; tuberculin skin test or interferon-gamma release assay; respiratory isolation |
| Fever + localized pain + recent surgery or instrumentation | Occult abscess | CT of relevant body region; blood cultures; interventional radiology or surgical drainage; IV antibiotics |
| Fever + new medication started 1-3 weeks ago + relatively well-appearing | Drug fever | Discontinue suspected medication; observe for defervescence (usually within 48-72 hours); supportive care |
| Fever + multisystem symptoms (rash, arthritis, serositis) + positive autoimmune markers | Autoimmune disease flare (systemic lupus erythematosus, vasculitis) | Autoimmune panel; complement levels; rule out infection; rheumatology consultation; consider corticosteroids |
Algorithm C: Chronic Fever / Fever of Unknown Origin (Greater than 21 days)
| Step | Actions | Expected Yield |
|---|---|---|
| Step 1: Re-evaluate | Detailed history review (travel, exposures, medications, family history); repeat physical examination; review all previous tests | May identify missed clues in approximately 10-15% of cases |
| Step 2: Repeat baseline tests | Complete blood count, comprehensive metabolic panel, liver function tests, lactate dehydrogenase, erythrocyte sedimentation rate, C-reactive protein, urinalysis, blood cultures | May reveal evolving abnormalities |
| Step 3: Targeted testing | HIV test, tuberculin skin test or interferon-gamma release assay, antinuclear antibody, cytomegalovirus and Epstein-Barr virus serologies, ferritin | Identifies specific diagnoses in approximately 20-30% |
| Step 4: Imaging | CT chest, abdomen, pelvis with contrast; echocardiography; consider PET-CT if CT unrevealing | CT identifies source in approximately 20-30%; PET-CT in approximately 40-70% |
| Step 5: Tissue diagnosis | Biopsy of any abnormality (lymph node, liver, bone marrow); temporal artery biopsy if over 50 with elevated erythrocyte sedimentation rate | Definitive diagnosis in majority of cases with identifiable target |
| Step 6: Empiric trials or observation | If all tests negative: consider empiric anti-tuberculosis therapy, corticosteroids for suspected autoimmune, or watchful waiting | Approximately 10-20% remain undiagnosed; most resolve spontaneously with good prognosis |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has fever but appears well with normal vital signs? | Obtain baseline investigations; thorough history and examination for localizing signs | If source identified, treat appropriately; if no source, close follow-up in 24-48 hours with clear return precautions |
| Blood cultures are positive? | Assess for source; repeat blood cultures to document clearance; adjust antibiotics based on susceptibilities | Echocardiography if Staphylococcus aureus or Enterococcus; search for metastatic infection; determine duration of therapy |
| Patient not improving on antibiotics after 48-72 hours? | Reassess diagnosis; look for undrained collection, resistant organism, or wrong diagnosis | Consider imaging for abscess; broaden antibiotic coverage; consider drug fever or non-infectious cause |
| Fever persists but all cultures are negative? | Consider culture-negative endocarditis, tuberculosis, fungal infection, viral infection, non-infectious causes | Expand testing (serologies, PCR, autoimmune panel); consider PET-CT; review medications for drug fever |
| Patient is immunocompromised with fever? | Treat as high-risk regardless of appearance; empiric broad-spectrum antibiotics; consider opportunistic infections | Tailor workup to specific immunocompromise (neutropenia, HIV, transplant); consider early infectious disease consultation |
| Elderly patient with low-grade fever and nonspecific symptoms? | Maintain high suspicion for serious infection; remember blunted febrile response; lower threshold for investigation | Urinalysis, chest radiograph, blood cultures; consider CT if no source; closely monitor for deterioration |
| Fever develops during hospitalization? | Consider healthcare-associated infections: line infection, urinary catheter infection, Clostridioides difficile, surgical site infection, ventilator-associated pneumonia | Remove or change lines, discontinue urinary catheters if possible; test for Clostridioides difficile if diarrhea; examine surgical sites |
| Patient requests antibiotics for presumed viral infection? | Explain viral etiology and self-limited course; discuss antibiotic resistance and adverse effects | Provide symptomatic treatment recommendations; establish clear follow-up plan; give specific return precautions |
Troubleshooting Refractory Fever
Ask These Questions When Fever Persists Despite Treatment
- Is the diagnosis correct? — Consider alternative diagnoses; viral infection treated as bacterial; non-infectious cause
- Is there an undrained collection? — Abscesses require drainage, not just antibiotics; repeat imaging
- Is the antibiotic appropriate? — Coverage adequate? Penetration to site of infection? Bioavailability adequate?
- Is there a resistant organism? — Review culture susceptibilities; consider empiric broadening if pending
- Is the patient compliant? — Taking medications as prescribed? Able to tolerate oral medications?
- Is this drug fever? — Antibiotics themselves can cause fever; patient may appear relatively well
- Is there a second diagnosis? — Concurrent infection, superinfection, or non-infectious condition
- Is the duration of treatment adequate? — Some infections require prolonged therapy (endocarditis, osteomyelitis, tuberculosis)
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Fever is a regulated response: Distinguish fever (elevated hypothalamic set point) from hyperthermia (uncontrolled temperature rise). This distinction has important therapeutic implications.
- Classification by duration guides the differential: Acute (less than 7 days) is usually infectious; subacute (7-21 days) expands the differential; chronic (greater than 3 weeks) enters fever of unknown origin territory requiring systematic investigation.
- The “Big Four” categories: Infection (most common), malignancy, autoimmune/inflammatory conditions, and miscellaneous causes account for virtually all cases of prolonged fever. Approximately 10-20% remain undiagnosed despite thorough evaluation.
- History and physical examination remain paramount: A thorough history (including exposures, travel, medications, and immunization status) and complete physical examination will identify the source or narrow the differential in the majority of cases.
- Identify the sick patient early: Use vital signs, qSOFA criteria, and clinical appearance to identify patients requiring urgent intervention. Sepsis kills through delay — early recognition and treatment save lives.
- Special populations require special attention: The elderly, immunocompromised, and post-surgical patients may present atypically. Maintain a lower threshold for investigation and treatment in these groups.
- Blood cultures before antibiotics, but never delay treatment: Obtaining cultures before antibiotics improves diagnostic yield, but in critically ill patients, antibiotic administration takes priority. The goal is cultures AND antibiotics within 1 hour in sepsis.
- A systematic approach prevents missed diagnoses: Use structured frameworks for history (FEVER mnemonic), examination (head-to-toe), and investigation (baseline then targeted). This ensures comprehensive evaluation while maintaining efficiency.
Quick Reference Algorithm
Systematic Approach to Fever:
- Assess urgency: Vital signs, mental status, appearance — identify patients requiring immediate intervention (sepsis, meningitis, necrotizing fasciitis)
- Characterize the fever: Duration (acute, subacute, chronic), pattern, maximum temperature, associated symptoms
- Obtain comprehensive history: Use FEVER mnemonic — Fever characteristics, Exposures, Vital associated symptoms, Existing conditions and medications, Red flags
- Perform thorough examination: Head-to-toe approach; do not neglect skin, lymph nodes, heart, and joints
- Order appropriate investigations: Baseline tests for all; targeted testing based on clinical suspicion; escalate if initial workup unrevealing
- Initiate treatment: Empiric antibiotics if bacterial infection suspected (urgently in sepsis); source control (drainage of abscesses); supportive care
- Reassess and adjust: If not improving at 48-72 hours, reconsider diagnosis, look for undrained collections, broaden coverage, or consider non-infectious causes
- Arrange appropriate follow-up: Close monitoring for high-risk patients; clear return precautions for those managed as outpatients